By contrast, locally primed antigen-specific T cells are less permissive to HIV-1 infection, as CCR5 agonists compete with HIV-1 for binding sites of the CCR5 receptor resulting in an inhibitory effect for HIV-1 entry 14, 30, 33. The gene discussed is CCR5; the disease is HIV-1 infection.